Jan E. Heeg

711 total citations
7 papers, 529 citations indexed

About

Jan E. Heeg is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Jan E. Heeg has authored 7 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 2 papers in Molecular Biology and 2 papers in Nephrology. Recurrent topics in Jan E. Heeg's work include Renin-Angiotensin System Studies (5 papers), Blood Pressure and Hypertension Studies (5 papers) and Protein Hydrolysis and Bioactive Peptides (2 papers). Jan E. Heeg is often cited by papers focused on Renin-Angiotensin System Studies (5 papers), Blood Pressure and Hypertension Studies (5 papers) and Protein Hydrolysis and Bioactive Peptides (2 papers). Jan E. Heeg collaborates with scholars based in Netherlands, Pakistan and United States. Jan E. Heeg's co-authors include Dick de Zeeuw, G. K. van der Hem, Paul E. de Jong, Michiel L. Bots, Henk J.G. Bilo, Arno W. Hoes, Monika Hollander and Arnoud W.J. van ‘t Hof and has published in prestigious journals such as Kidney International, Clinical Science and Journal of Cardiovascular Pharmacology.

In The Last Decade

Jan E. Heeg

7 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan E. Heeg Netherlands	6	319	254	171	99	86	7	529
A J Apperloo Netherlands	6	235 0.7×	194 0.8×	144 0.8×	58 0.6×	25 0.3×	7	419
P.E. de Jong Netherlands	12	172 0.5×	189 0.7×	103 0.6×	103 1.0×	37 0.4×	15	415
Makoto Ishizaki Japan	7	193 0.6×	190 0.7×	146 0.9×	57 0.6×	21 0.2×	31	457
Giacomina Loriga Italy	8	381 1.2×	234 0.9×	146 0.9×	54 0.5×	101 1.2×	11	604
Miriam Parker United States	7	242 0.8×	197 0.8×	88 0.5×	63 0.6×	84 1.0×	10	435
Svend Aage Johnsen Sweden	5	316 1.0×	290 1.1×	237 1.4×	50 0.5×	18 0.2×	6	528
Gen Futaki Japan	4	186 0.6×	160 0.6×	146 0.9×	42 0.4×	19 0.2×	7	362
Hans-Henrik Parving Denmark	9	246 0.8×	452 1.8×	262 1.5×	72 0.7×	12 0.1×	10	689
Raffaella Riccobene Italy	10	253 0.8×	221 0.9×	64 0.4×	66 0.7×	67 0.8×	13	528
Pe Dejong Pakistan	9	152 0.5×	148 0.6×	103 0.6×	38 0.4×	22 0.3×	19	330

Countries citing papers authored by Jan E. Heeg

Since Specialization

Citations

This map shows the geographic impact of Jan E. Heeg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan E. Heeg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan E. Heeg more than expected).

Fields of papers citing papers by Jan E. Heeg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan E. Heeg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan E. Heeg. The network helps show where Jan E. Heeg may publish in the future.

Co-authorship network of co-authors of Jan E. Heeg

This figure shows the co-authorship network connecting the top 25 collaborators of Jan E. Heeg. A scholar is included among the top collaborators of Jan E. Heeg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan E. Heeg. Jan E. Heeg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Hof, Arnoud W.J. van ‘t, Henk J.G. Bilo, Jan E. Heeg, et al.. (2021). Integrated cardiovascular risk management programme versus usual care in patients at high cardiovascular risk: an observational study in general practice. BJGP Open. 5(2). BJGPO.2020.0099–BJGPO.2020.0099. 1 indexed citations

2.

Heeg, Jan E., et al.. (1992). The Antiproteinuric Effects of Blood Pressure-Lowering Agents: Differences Between Nondiabetics and Diabetics. Journal of Cardiovascular Pharmacology. 19. S28–S32. 7 indexed citations

3.

Heeg, Jan E., Paul E. de Jong, & Dick de Zeeuw. (1991). Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: A clue to the mechanism of action. Clinical Science. 81(3). 367–372. 15 indexed citations

4.

Heeg, Jan E., et al.. (1991). Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition. Kidney International. 40(4). 734–741. 43 indexed citations

5.

Jong, Paul E. de, et al.. (1990). Lisinopril in Hypertensive Patients with Renal Function Impairment. The Nephron journals/Nephron journals. 55(1). 43–48. 10 indexed citations

6.

Heeg, Jan E., et al.. (1989). Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney International. 36(2). 272–279. 279 indexed citations

7.

Heeg, Jan E., Paul E. de Jong, G. K. van der Hem, & Dick de Zeeuw. (1987). Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney International. 32(1). 78–83. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact